Detalhe da pesquisa
1.
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the XELBEVOCT study.
BMC Cancer
; 14: 184, 2014 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-24628963
2.
Randomized phase II study of danusertib in patients with metastatic castration-resistant prostate cancer after docetaxel failure.
BJU Int
; 111(1): 44-52, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22928785
3.
Risk factors for disease progression in advanced jejunoileal neuroendocrine tumors.
Neuroendocrinology
; 96(1): 32-40, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22205326
4.
The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.
Breast Cancer Res
; 13(1): R16, 2011 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-21291529
5.
Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic review.
Oncologist
; 16(9): 1215-27, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21835895
6.
Prevalence of complementary/alternative medicines (CAMs) in a cancer population in northern Italy receiving antineoplastic treatments and relationship with quality of life and psychometric features.
Qual Life Res
; 20(5): 683-90, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21080084
7.
The prognostic role of immunohistochemical chromogranin a expression in prostate cancer patients is significantly modified by androgen-deprivation therapy.
Prostate
; 70(7): 718-26, 2010 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20087896
8.
Adjuvant mitotane treatment for adrenocortical carcinoma.
N Engl J Med
; 356(23): 2372-80, 2007 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-17554118
9.
Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients.
Breast Cancer Res Treat
; 123(3): 795-804, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20680681
10.
Immunomodulation of FOXP3+ regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients.
Clin Cancer Res
; 15(3): 1046-51, 2009 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19188178
11.
Restless legs syndrome and its relationship with anxiety, depression, and quality of life in cancer patients undergoing chemotherapy.
Qual Life Res
; 19(4): 531-7, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20195906
12.
Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte oncology network.
BMC Cancer
; 9: 388, 2009 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-19886987
13.
Thymidylate synthase expression in gastroenteropancreatic and pulmonary neuroendocrine tumors.
Clin Cancer Res
; 14(4): 1059-64, 2008 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18281538
14.
Down-regulation of phosphatidylinositol 3'-kinase/AKT/molecular target of rapamycin metabolic pathway by primary letrozole-based therapy in human breast cancer.
Clin Cancer Res
; 14(9): 2673-80, 2008 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18451231
15.
Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly.
Endocr Relat Cancer
; 15(4): 1043-53, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18824557
16.
Presurgical systemic treatment of nonmetastatic breast cancer: facts and open questions.
Oncologist
; 13(11): 1137-48, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18997125
17.
Emerging drugs for adrenocortical carcinoma.
Expert Opin Emerg Drugs
; 13(3): 497-509, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18764725
18.
Gemcitabine and protracted 5-fluorouracil infusion as third-line chemotherapy in refractory colorectal cancer patients.
Anticancer Res
; 28(5B): 3055-60, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-19031956
19.
Regulation of hepatocyte growth factor activator inhibitor 2 by hypoxia in breast cancer.
Clin Cancer Res
; 13(2 Pt 1): 550-8, 2007 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17255277
20.
Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study.
Endocr Relat Cancer
; 14(2): 473-82, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17639060